Evidence map›Paper›PMID 16000434›Full record

ArticleJournal of clinical microbiology2005

Detection of Balamuthia mitochondrial 16S rRNA gene DNA in clinical specimens by PCR.

Shigeo Yagi, Gregory C Booton, Govinda S Visvesvara, Frederick L Schuster

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 78 citations in OpenAlex.

  1. Pulmonary infection due toASM case reports · 2025
    Article
  2. Article
  3. Opportunistic free-living amoebal pathogens.Pathogens and global health · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Encephalomyelitis Caused byFrontiers in immunology · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Diagnosis of infections caused by pathogenic free-living amoebae.Interdisciplinary perspectives on infectious diseases · 2009
    Article
  15. Article
  16. Emerging pathogens: challenges and successes of molecular diagnostics.The Journal of molecular diagnostics : JMD · 2008
    Review
  17. Article
  18. Article
  19. Balamuthia mandrillaris amebic encephalitis.Current infectious disease reports · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Shigeo YagiCalifornia Department of Health Services, Viral and Rickettsial Disease Laboratory, 850 Marina Bay Parkway, Richmond, CA 94804, USA. syagi@dhs.ca.gov
Gregory C Booton
Govinda S Visvesvara
Frederick L Schuster
California Health and Human Services Agency · USCenters for Disease Control and Prevention · USThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Balamuthia mandrillaris is a free-living ameba that causes granulomatous amebic encephalitis in both immunocompromised and immunocompetent individuals. Because of a lack of pathognomonic symptoms and the difficulty in recognizing amebas in biopsied tissues, most cases are not diagnosed or effectively treated, leading to a >95% mortality. We report here on five cases of balamuthiasis that were diagnosed by indirect immunofluorescence (IIF) staining of serum for anti-Balamuthia antibodies (titer > or = 1:128) and confirmed by IIF of unstained brain tissue sections and/or detection of amebas in hematoxylin-eosin-stained slides. Additionally, we have used the PCR for the detection of mitochondrial 16S rRNA gene DNA from the ameba in clinical specimens such as brain tissue and cerebrospinal fluid (CSF) from individuals with Balamuthia encephalitis. Balamuthia DNA was successfully detected by the PCR in clinical samples from all five individuals. It was detected in brain tissue from three cases, in CSF from three cases, and in one of two samples of lung tissue from two individuals, but not in two samples of kidney tissue tested. One sample of unfixed brain tissue was culture positive for Balamuthia. In order to test the sensitivity of the PCR for detection of Balamuthia DNA, CSF specimens from two individuals negative for amebic infection were spiked with Balamuthia amebas. We found that it was possible to detect Balamuthia DNA in the PCR mixtures containing mitochondrial DNA from 1 to as little as 0.2 ameba per reaction mixture. A single Balamuthia ameba contains multiple mitochondrial targets; thus, 0.2 ameba represents multiple targets for amplification and is not equivalent to 0.2 of an ameba as a target.

Indexed as

AmebiasisAnimalsBrainCentral Nervous System Protozoal InfectionsCerebrospinal FluidChildChild, PreschoolDNA, MitochondrialDNA, ProtozoanEncephalitisFemaleGenes, rRNAHumansLoboseaMaleMiddle AgedDNA, MitochondrialDNA, ProtozoanRNA, Ribosomal, 16S

Identifiers

PMID16000434
PMCPMC1169170
OpenAlexW2157336020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.